SHAREHOPE MEDICINE CO .﹐LTD.

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023

In its 2023 reporting, SHAREHOPE MEDICINE CO .﹐LTD. disclosed greenhouse gas emissions of 89.4 tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
89.4 tCO2e/year
2023
💧
Water Usage
672 m3/year
2023
♻️
Waste
2.29 tons/year
2023

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Reduce greenhouse gas emissions, water consumption, and waste production by another 5% by the end of 2025 (compared to 2020).

🌱 ESG Focus Areas

Environmental ProtectionLabor-Management RelationsCorporate Governance

⚠️ Challenges & Risks +

  • Reduction in business demand related to the epidemic.
  • Changes in drug and health insurance prices and related subsidy policies.
  • Fierce price-cutting competition in the pharmaceutical market.
  • Changes in national health examination laws and restrictions on health insurance benefits.
  • Pressure from clients to lower leasing interest requirements for medical equipment.
  • Potential competitors entering the market.

📋 Report Information

Reporting Period: 2023
Assurance: AFNOR (Aifano International Co., Ltd.) (planned for 2025)